
doi: 10.1148/47.4.377
pmid: 21003117
Following the publication of Maxfield's results in the treatment of radiation sickness by pyridoxine hydrochloride (vitamin B6) in 1943 (6), we became interested in this drug and subsequently began its use in radiation sickness at The Henry Ford Hospital. In order to give the drug a thorough trial, it was decided to limit its use to the more severe cases and not to use it prophylactically. With this in view, we arbitrarily classified our cases of radiation sickness into four groups: (1) mild (anorexia and some nausea); (2) moderate (rather severe nausea, distaste for food, and occasional vomiting); (3) severe (pronounced nausea and frequent vomiting); (4) late or inflammatory symptoms due to proctitis, enteritis, and cystitis. No medication was offered to patients falling in the first group. Those in the other three groups received intravenous injections of 25 to 50 mg. of pyridoxine hydrochloride, in the form of Hexabetalin, beginning with the onset of symptoms. No other medication was given to any patie...
X-Rays, Humans, Pyridoxine, Radiation Injuries
X-Rays, Humans, Pyridoxine, Radiation Injuries
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 8 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 10% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
